A company with the same founders as the specialty pharmacy linked to deadly meningitis outbreak says it's recalling all its products.
In a statement Wednesday, Ameridose said the voluntary recall comes after FDA officials told the company it must improve its sterility testing. The Westborough company says it has no reports of problems with its products, or any impurities, but issued the recall "out of an abundance of caution."
The company did not say how many products it is recalling.
Yesterday, Governor of Massachusetts Deval Patrick and the state Department of Public Health released more details of their investigation into the compounding pharmacy at the heart of a meningitis outbreak that has sickened more than 300 people. WAMC’s Berkshire Bureau Chief Lucas Willard reports…
Since injectable steroids manufactured and distributed by New England Compound Center in Framingham Massachusetts were discovered to be the cause of an outbreak of fungal meningitis, the Commonwealth has launched an investigation with Federal officials on the incident.
The outbreak of fungal meningitis linked to contaminated drugs manufactured by a Massachusetts company has claimed the lives of at least 14 people. Now federal and state officials are investigating but groups are calling for more action. WAMC’s Berkshire Bureau Chief Lucas Willard reports…
Long before the current rash of fungal meningitis, the compounding pharmacy suspected in the outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004.
Officials have identified Framingham, Mass., based-New England Compounding Center as the source of steroid shots suspected in the outbreak of rare fungal meningitis that has killed at least 12 people and made more than 130 others sick in 10 states.